LUKE M. BESHAR - 14 Mar 2022 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
Director
Signature
/s/ Karen Deschaine, Attorney-in-fact
Issuer symbol
TARA
Transactions as of
14 Mar 2022
Net transactions value
+$42,500
Form type
4
Filing time
16 Mar 2022, 16:37:48 UTC
Previous filing
14 Mar 2022
Next filing
09 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Purchase $42,500 +10,000 +5.6% $4.25 188,000 14 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.